Successful New Drug Development Strategies for Small Companies
1 Michael A. Swit, Esq. Vice President. The Forgotten Keys to Bio-Pharma Transactions – Regulatory, Clinical & Quality Challenges in Due Diligence and.
Paula M. Jacobs, Ph.D. SAIC Frederick Cancer Imaging Program/DCTD/NCI/NIH September 5, 2006 Phase 0 Trials in Oncologic Drug Development DCTD Phase 0 Workshop.
Inside the FDA
The Rough Waters of the Regulatory Environment
BIO 221REGULATORY COMPLIANCE IN BIOMANUFACTURING CHAPTER SUMMARIES.
Microbiotix, Inc. Program Update
